ETON · Eton Pharmaceuticals, Inc. · Proposed Sales
$63.93
+2.48 (+4.04%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$1.84B
Shares
28.84M
Volume · Nov 13
601.31K
Avg daily vol (3M)
618.9K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-11-10 | Erdogan-Trinkaus Ipek | Officer | 3,500 | 2026-11-10 | Raymond James & Associates, Inc. |
| 2026-11-10 | CASAMENTO CHARLES J | Director | 80,555 | 2026-11-10 | Raymond James & Associates Inc |
| 2026-10-06 | Krempa David | Officer | 4,166 | 2026-10-06 | Raymond James & Associates Inc. |
| 2026-08-28 | MAIER PAUL V | Director | 50,000 | 2026-08-28 | Raymond James and Associates inc. |
| 2026-08-24 | Krempa David | Officer | 25,000 | 2026-08-24 | Raymond James and Associates |
| 2026-08-19 | BRYNJELSEN SEAN | Director, 10% Stockholder | 100,000 | 2026-08-19 | Raymond James and Associates Inc. |
| 2026-06-26 | Gruber James R. | Officer | 251,818 | 2026-06-26 | Raymond James & Associates |
| 2026-06-25 | Gruber James R. | Officer | 25,000 | 2026-06-25 | Raymond James & Associates |
| 2026-06-23 | Gruber James R. | Officer | 25,000 | 2026-06-23 | Raymond James & Associates |
| 2026-06-17 | Adams Jennifer McKie | Director | 50,000 | 2026-06-17 | Raymond James & Associates |
| 2026-06-02 | Gruber James R. | Officer | 3,117 | 2026-06-02 | Raymond James & Associates |
| 2026-05-28 | BRYNJELSEN SEAN | Director | 120,000 | 2026-05-28 | The Charles Schwab Corporation |
| 2026-05-22 | Krempa David | Officer | 100,000 | 2026-05-22 | Raymond James & Associates, Inc. |
| 2026-01-14 | BRYNJELSEN SEAN | Officer, Director, 10% Stockholder | 5,015 | 2026-01-14 | RAYMOND JAMES & ASSOCIATES |
| 2026-01-14 | Krempa David | Officer | 1,942 | 2026-01-14 | Raymond James & Associates |
| 2026-01-14 | Gruber James R. | Officer | 2,293 | 2026-01-14 | Raymond James & Associates |
| 2025-12-12 | Gruber James R. | Officer | 5,450 | 2025-12-12 | Raymond James & Associates |
| 2025-12-12 | BRYNJELSEN SEAN | Officer, Director, 10% Stockholder | 8,035 | 2025-12-12 | Raymond James & Associates |
| 2025-12-12 | Erdogan-Trinkaus Ipek | Officer | 99 | 2025-12-12 | Raymond James & Associates |
| 2025-12-12 | Krempa David | Officer | 7,545 | 2025-12-12 | Raymond James & Associates |
| 2025-08-19 | Gruber James R. | Officer | 41,713 | 2025-08-18 | Raymond James & Associates |
| 2025-06-12 | Krempa David | Officer | 40,000 | 2025-06-12 | Raymond James & Associates |
| 2025-06-03 | BRYNJELSEN SEAN | Officer, Director, 10% Stockholder | 210,000 | 2025-06-03 | Raymond James & Associates |
Showing 1–23 of 23 filings
Key facts
CIK
1710340
CUSIP
29772L108
13F (30d)
154 filings
151 filers
Visit website
Investor relations